scispace - formally typeset
R

Rama Shanker Verma

Researcher at Indian Institute of Technology Madras

Publications -  167
Citations -  3945

Rama Shanker Verma is an academic researcher from Indian Institute of Technology Madras. The author has contributed to research in topics: Stem cell & Mesenchymal stem cell. The author has an hindex of 30, co-authored 159 publications receiving 3160 citations. Previous affiliations of Rama Shanker Verma include University of Pennsylvania & Thapar University.

Papers
More filters
Journal ArticleDOI

Organotypic cancer tissue models for drug screening: 3D constructs, bioprinting and microfluidic chips.

TL;DR: This review projects the progress toward biomimetic tissue model development, highlighting the emergence of bioprinting and microfluidic technology in in vitro cancer drug screening and pertaining challenges.
Journal ArticleDOI

Effect of perturbation of specific folate receptors during in vitro erythropoiesis.

TL;DR: Data support the conclusion that folate receptors on marrow cells provide an important function in the cellular uptake of folates during in vitro erythropoiesis and play a pivotal role in the differentiation and proliferation of erythroid progenitor cells.
Journal ArticleDOI

Evaluation of platelet lysate as a substitute for FBS in explant and enzymatic isolation methods of human umbilical cord MSCs

TL;DR: Platelet lysate from expired platelets is a viable alternative to FBS for generating clinically relevant numbers of MSC from explant cultures over enzymatic method and shows typical immunophenotype, plasticity, immunomodulatory property and chromosomal stability.
Journal ArticleDOI

Role of protein tyrosine phosphorylation in H2O2-induced activation of endothelial cell phospholipase D.

TL;DR: Results suggest that tyrosine kinase activation may be involved in H2O2-induced PLD activation in vascular endothelial cells.
Journal ArticleDOI

Cardiomyocyte culture - an update on the in vitro cardiovascular model and future challenges.

TL;DR: This review discusses the use of freshly isolated murine cardiomyocytes andCardiomyocyte alternatives for use in cardiac disease models and other related studies.